CellxLife
PrivateCompany Overview
CellxLife is a biotechnology company that develops immuno-therapeutic cancer vaccines, with an initial focus on a dendritic cell-derived vaccine therapy targeting metastatic Ewing sarcoma and osteosarcoma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
cancer vaccinedendritic cell therapyautologous immunotherapycell therapyimmunotherapypediatric oncologypersonalized cancer vaccineEwing sarcomaosteosarcomaclinical stage biotechtherapeutic vaccinepediatric bone cancersolid tumor therapybiotherapy
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellxLife Comparables
Compare CellxLife with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Diakonos Oncology | 87% | |
| Northwest Biotherapeutics Inc | 81% | |
| Corner Therapeutics | 78% | |
CellxLife Funding Rounds
Historical fundraising activity
CellxLife Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CellxLife's valuation, stock price, and market status.
See something wrong or outdated?